Lectin-Galactoside Binding Soluble 3 (LGALS3) Antibody

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
Description
This product is currently in development. The lead time for this product may be several months. Please contact us at
Documents del producto
Product specifications
Category | Primary Antibodies |
Immunogen Target | Lectin-Galactoside Binding Soluble 3 (LGALS3) |
Host | Mouse |
Reactivity | Human |
Recommended Dilution | WB: 1/500 - 1/4000. Optimal dilutions/concentrations should be determined by the end user. |
Clonality | Monoclonal |
Conjugation | Unconjugated |
Isotype | IgG1 |
Purification | Unpurified crude ascites. |
Size 1 | 100 µl |
Form | Liquid |
Tested Applications | ELISA, WB |
Buffer | Ascites containing 0.09% sodium azide. |
Availability | Please enquire. |
Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
Dry Ice | No |
UniProt ID | P17931 |
Background | Antibody anti-LGALS3 |
Status | RUO |
Descripción
Related Products

LGALS3 antibody
Galectins are a family of animal lectins defined by shared characteristic amino-acid sequences and affinity for β-galactose-containing oligosac-charides(PMID: 8063692). Galectin-3 contains one carbohydrate recognition domain(CRD) and a proline-and glycine-rich N-terminal domain through which is able to form oligomers. Galectin-3 is widely expressed in many normal tissues and a variety of tumors.
Ver Producto
LGALS3 antibody
Galectins are a family of animal lectins defined by shared characteristic amino-acid sequences and affinity for β-galactose-containing oligosac-charides(PMID: 8063692). Galectin-3 contains one carbohydrate recognition domain(CRD) and a proline-and glycine-rich N-terminal domain through which is able to form oligomers. Galectin-3 is widely expressed in many normal tissues and a variety of tumors.
Ver Producto